Marlene Maria Speth
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Marlene Maria Speth has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
A. R. Sedaghat
Department of Otolaryngology – Head and Neck Surgery, University of Cincinnati College of Medicine, Cincinnati, USA
2 shared publicationsAhmad R. Sedaghat
Department of Otolaryngology- Head and Neck Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
2 shared publications- Anna Onderková
University Hospital Královské Vinohrady Department of Otorhinolaryngology Prague, 100 34
2 shared publications Nader Ahmad
HNO, Kantonsspital Aarau AG, Aarau, Switzerland
2 shared publicationsT. Hummel
Universitäts-HNO Klinik, TU Dresden, Dresden, Deutschland
2 shared publicationsU. S. Speth
Klinik für Mund‑, Kiefer-, und Gesichtschirurgie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Deutschland
2 shared publications
Latest Publications
- Open Access
- 16 November 2026
- Published by Wiley in Head & Neck
EUSICA / INSICA Position Paper on Squamous Cell Carcinoma of the Nasal Vestibule: A Distinct Clinical Entity Requiring Dedicated Classification, Treatment Strategies and Outcome Measures
Purpose: Cancer of the nasal vestibule (CNV) differs anatomically and clinically from both sinonasal and cutaneous squamous cell carcinoma, yet lacks formal recognition as a separate clinical entity and topographical subsite; whether it is also biologically distinct has not yet been investigated. EUSICA/INSICA advocates for formal recognition of CNV and a unified classification, treatment, and translational framework. Method: Published literature on CNV, including population‐based cohorts, T‐classification studies, brachytherapy outcomes, and quality‐of‐life data, was reviewed by an international multidisciplinary EUSICA/INSICA expert panel to formulate consensus recommendations. Finding: CNV shows favorable outcomes, drains preferentially to facial and submandibular nodes, and is amenable to organ‐preserving radiotherapy, in particular brachytherapy. It is staged using four non‐uniform systems; multicenter validation in 609 patients from 21 centers supported the prognostic utility of the New Rome classification integrated with clinical nodal status. Validated CNV‐specific quality‐of‐life instruments are lacking. Compared with NCCN‐defined high‐risk cutaneous SCC of the nose, CNV differs in topography, pattern of local spread, prognostic landmarks, nodal behavior, and treatment paradigm. Comparative molecular data versus cutaneous and sinonasal SCC are not yet available. Conclusion: EUSICA/INSICA calls for formal recognition of CNV as a distinct ICD‐O‐3 subsite, incorporation of the New Rome T classification into UICC/AJCC TNM, standardized organ‐preserving treatment, and dedicated translational research, including comparative molecular studies to determine whether its clinical distinctness has a biological basis.
- 16 November 2026
- Published by Wiley in Head & Neck
Open AccessEUSICA / INSICA Position Paper on Squamous Cell Carcinoma of the Nasal Vestibule: A Distinct Clinical Entity Requiring Dedicated Classification, Treatment Strategies and Outcome Measures
Purpose: Cancer of the nasal vestibule (CNV) differs anatomically and clinically from both sinonasal and cutaneous squamous cell carcinoma, yet lacks formal recognition as a separate clinical entity and topographical subsite; whether it is also biologically distinct has not yet been investigated. EUSICA/INSICA advocates for formal recognition of CNV and a unified classification, treatment, and translational framework. Method: Published literature on CNV, including population‐based cohorts, T‐classification studies, brachytherapy outcomes, and quality‐of‐life data, was reviewed by an international multidisciplinary EUSICA/INSICA expert panel to formulate consensus recommendations. Finding: CNV shows favorable outcomes, drains preferentially to facial and submandibular nodes, and is amenable to organ‐preserving radiotherapy, in particular brachytherapy. It is staged using four non‐uniform systems; multicenter validation in 609 patients from 21 centers supported the prognostic utility of the New Rome classification integrated with clinical nodal status. Validated CNV‐specific quality‐of‐life instruments are lacking. Compared with NCCN‐defined high‐risk cutaneous SCC of the nose, CNV differs in topography, pattern of local spread, prognostic landmarks, nodal behavior, and treatment paradigm. Comparative molecular data versus cutaneous and sinonasal SCC are not yet available. Conclusion: EUSICA/INSICA calls for formal recognition of CNV as a distinct ICD‐O‐3 subsite, incorporation of the New Rome T classification into UICC/AJCC TNM, standardized organ‐preserving treatment, and dedicated translational research, including comparative molecular studies to determine whether its clinical distinctness has a biological basis.
- 27 July 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (7) , e267664
Loss of vision secondary to a sphenoid fungal ball with full post-surgical recovery
An older adolescent immunocompetent male with a 2 month history of progressive frontal headaches, congestion and worsening vision, culminating in right optic neuropathy, was referred to our emergency department by ophthalmology. MRI revealed extensive sinus disease, though without direct optic nerve compression; CT scan identified a fungal ball extending into the right clinoid process, with bony erosion and involvement of the deep pneumatised optico-carotid recess. The patient underwent emergency endoscopic sinus surgery, where mucopus, polyps and fungal debris consistent with an infected fungal ball were found in the right nasal cavity and sphenoid sinus. Residual fungal material remained in the deep optico-carotid recess post-washout due to difficult access and dehiscent bony coverings of the optic nerve and carotid. Postoperatively, he was treated with voriconazole and intravenous co-amoxiclav. His vision returned to baseline 3 days postoperative and 3 months later, a second-look surgery confirmed no residual fungal material. Now fully recovered and discharged from follow-up.
- 27 July 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (7) , e267664
Loss of vision secondary to a sphenoid fungal ball with full post-surgical recovery
An older adolescent immunocompetent male with a 2 month history of progressive frontal headaches, congestion and worsening vision, culminating in right optic neuropathy, was referred to our emergency department by ophthalmology. MRI revealed extensive sinus disease, though without direct optic nerve compression; CT scan identified a fungal ball extending into the right clinoid process, with bony erosion and involvement of the deep pneumatised optico-carotid recess. The patient underwent emergency endoscopic sinus surgery, where mucopus, polyps and fungal debris consistent with an infected fungal ball were found in the right nasal cavity and sphenoid sinus. Residual fungal material remained in the deep optico-carotid recess post-washout due to difficult access and dehiscent bony coverings of the optic nerve and carotid. Postoperatively, he was treated with voriconazole and intravenous co-amoxiclav. His vision returned to baseline 3 days postoperative and 3 months later, a second-look surgery confirmed no residual fungal material. Now fully recovered and discharged from follow-up.
- 16 July 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (7) , e270418
Sphenochoanal polyp arising from the sphenoid ostium and mimicking an antrochoanal polyp on preoperative imaging
A man in his early 20s presented with an 8-month history of unilateral nasal obstruction, hyposmia and thick nasal discharge, unresponsive to topical therapy. Preoperative CT demonstrated a smooth polypoidal mass occupying the left nasal cavity and extending into the postnasal space, most consistent with a choanal polyp of presumed maxillary origin. Endoscopic sinus surgery revealed a pedicle at the sphenoid ostium, with an otherwise clear sphenoid sinus, confirming a sphenochoanal polyp. This was unusual because preoperative CT showed only minimal mucosal change in the sphenoid sinus, a finding that typically argues against a sphenochoanal origin. The lesion was excised endoscopically at its site of attachment. Histopathology showed inflammatory nasal polyp tissue without granulomata, vasculitis or atypia. This case illustrates a diagnostic pitfall in which sphenochoanal polyps may mimic antrochoanal polyps on imaging; intraoperative identification of the true sinus of origin is essential to guide appropriate surgery and minimise recurrence.
- 16 July 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (7) , e270418
Sphenochoanal polyp arising from the sphenoid ostium and mimicking an antrochoanal polyp on preoperative imaging
A man in his early 20s presented with an 8-month history of unilateral nasal obstruction, hyposmia and thick nasal discharge, unresponsive to topical therapy. Preoperative CT demonstrated a smooth polypoidal mass occupying the left nasal cavity and extending into the postnasal space, most consistent with a choanal polyp of presumed maxillary origin. Endoscopic sinus surgery revealed a pedicle at the sphenoid ostium, with an otherwise clear sphenoid sinus, confirming a sphenochoanal polyp. This was unusual because preoperative CT showed only minimal mucosal change in the sphenoid sinus, a finding that typically argues against a sphenochoanal origin. The lesion was excised endoscopically at its site of attachment. Histopathology showed inflammatory nasal polyp tissue without granulomata, vasculitis or atypia. This case illustrates a diagnostic pitfall in which sphenochoanal polyps may mimic antrochoanal polyps on imaging; intraoperative identification of the true sinus of origin is essential to guide appropriate surgery and minimise recurrence.
- 27 November 2024
- Published by Wolters Kluwer Health in Current Opinion in Otolaryngology & Head and Neck Surgery
- Vol. 33 (1) , 1-6
Chronic rhinosinusitis and asthma: epidemiology, pathophysiology, morbidity, treatment
Purpose of review: Especially with the advent of biologics which have originally been prescribed primarily for pulmonary disease, the interconnections between asthma and chronic rhinosinusitis are becoming even more apparent. Biologics can now also be prescribed for chronic rhinosinusitis in some countries. But what is the epidemiology, pathophysiology and treatment of both diseases? Recent findings: This review covers the epidemiology, pathophysiology, morbidity and treatment of both diseases. Specifically, this review highlights the interdependencies of both diseases and potential future treatment options. Summary: This review aims to alert physicians to go beyond treating only one of the diseases, but rather to get a broader picture of the diseases and treatment options.
- 27 November 2024
- Published by Wolters Kluwer Health in Current Opinion in Otolaryngology & Head and Neck Surgery
- Vol. 33 (1) , 1-6
Chronic rhinosinusitis and asthma: epidemiology, pathophysiology, morbidity, treatment
Purpose of review: Especially with the advent of biologics which have originally been prescribed primarily for pulmonary disease, the interconnections between asthma and chronic rhinosinusitis are becoming even more apparent. Biologics can now also be prescribed for chronic rhinosinusitis in some countries. But what is the epidemiology, pathophysiology and treatment of both diseases? Recent findings: This review covers the epidemiology, pathophysiology, morbidity and treatment of both diseases. Specifically, this review highlights the interdependencies of both diseases and potential future treatment options. Summary: This review aims to alert physicians to go beyond treating only one of the diseases, but rather to get a broader picture of the diseases and treatment options.
- Open Access
- 18 June 2024
- Published by BMJ in BMJ Case Reports
- Vol. 17 (6) , e259725
Disseminated nocardiosis presenting as a superinfected thyroglossal duct cyst in a patient with diabetes
We introduce the case of a male patient in his 60s who was admitted to our emergency department with a persisting sore throat for the last 3 weeks and dysphagia. Fibre-endoscopic evaluation revealed an asymmetry at the base of the tongue. In combination with elevated white cell count and C reactive protein, a computerized tomography showed a superinfected thyroglossal duct cyst. Intravenous antibiotics were initiated, and the patient was taken to the operating room for cervicotomy. The microbiological swab taken intraoperatively detected Nocardia paucivorans. Additional imaging revealed disseminated nocardiosis with cerebral and pulmonary manifestations. The patient was treated with oral trimethoprim/sulfamethoxazole and, over time, showed complete remission of central nervous system lesions and improvement of pulmonary involvement. Following this, the treatment was stopped 8 months after the initial diagnosis. In this report, we discuss treatment standards and outcomes of nocardiosis based on our management strategies of our patient.
- 18 June 2024
- Published by BMJ in BMJ Case Reports
- Vol. 17 (6) , e259725
Open AccessDisseminated nocardiosis presenting as a superinfected thyroglossal duct cyst in a patient with diabetes
We introduce the case of a male patient in his 60s who was admitted to our emergency department with a persisting sore throat for the last 3 weeks and dysphagia. Fibre-endoscopic evaluation revealed an asymmetry at the base of the tongue. In combination with elevated white cell count and C reactive protein, a computerized tomography showed a superinfected thyroglossal duct cyst. Intravenous antibiotics were initiated, and the patient was taken to the operating room for cervicotomy. The microbiological swab taken intraoperatively detected Nocardia paucivorans. Additional imaging revealed disseminated nocardiosis with cerebral and pulmonary manifestations. The patient was treated with oral trimethoprim/sulfamethoxazole and, over time, showed complete remission of central nervous system lesions and improvement of pulmonary involvement. Following this, the treatment was stopped 8 months after the initial diagnosis. In this report, we discuss treatment standards and outcomes of nocardiosis based on our management strategies of our patient.
- 20 October 2022
- Published by Elsevier in The Lancet
- Vol. 400 (10361) , 1401
Maintaining contact with clinical colleagues in Myanmar
- 20 October 2022
- Published by Elsevier in The Lancet
- Vol. 400 (10361) , 1401
Maintaining contact with clinical colleagues in Myanmar
- 13 April 2022
- Published by Springer Nature in DGNeurologie
- Vol. 5 (3) , 225-235
Riech- und Schmeckstörungen
Ziel der vorliegenden Übersicht ist es, einen Überblick über die Ätiologie und Diagnostik von Riech- und Schmeckstörungen zu geben. Da etwa 5 % der Allgemeinbevölkerung betroffen sind, ist es ein häufiges Krankheitsbild. Riechen und Schmecken erhielten v. a. zuletzt Aufmerksamkeit während des Aufkommens der SARS-CoV-2-Pandemie, wobei eine plötzlich aufgetretene Riech- und/oder Schmeckstörung zu den typischen Symptomen zählt. Daneben sind Riechstörungen in der Frühdiagnostik neurodegenerativer Erkrankungen von Bedeutung. Häufig zeigen Patienten mit Riechstörungen Zeichen einer Depression. Die Auswirkungen von Riech‑/Schmeckstörungen sind also umfangreich, die Therapiemöglichkeiten aktuell begrenzt. Nach einem Einblick in die Ätiologie werden Diagnostik und Therapiemöglichkeiten auf dem aktuellen Stand der Literatur erörtert. Auch zukunftsweisende Behandlungsvorstellungen, wie z. B. autologe Schleimhauttransplantationen oder olfaktorische Implantate, werden angesprochen.
- 13 April 2022
- Published by Springer Nature in DGNeurologie
- Vol. 5 (3) , 225-235
Riech- und Schmeckstörungen
Ziel der vorliegenden Übersicht ist es, einen Überblick über die Ätiologie und Diagnostik von Riech- und Schmeckstörungen zu geben. Da etwa 5 % der Allgemeinbevölkerung betroffen sind, ist es ein häufiges Krankheitsbild. Riechen und Schmecken erhielten v. a. zuletzt Aufmerksamkeit während des Aufkommens der SARS-CoV-2-Pandemie, wobei eine plötzlich aufgetretene Riech- und/oder Schmeckstörung zu den typischen Symptomen zählt. Daneben sind Riechstörungen in der Frühdiagnostik neurodegenerativer Erkrankungen von Bedeutung. Häufig zeigen Patienten mit Riechstörungen Zeichen einer Depression. Die Auswirkungen von Riech‑/Schmeckstörungen sind also umfangreich, die Therapiemöglichkeiten aktuell begrenzt. Nach einem Einblick in die Ätiologie werden Diagnostik und Therapiemöglichkeiten auf dem aktuellen Stand der Literatur erörtert. Auch zukunftsweisende Behandlungsvorstellungen, wie z. B. autologe Schleimhauttransplantationen oder olfaktorische Implantate, werden angesprochen.
- 12 January 2022
- Published by Springer Nature in HNO
- Vol. 70 (2) , 1-10
Riech- und Schmeckstörungen
Zusammenfassung Ziel der vorliegenden Übersicht ist es, einen Überblick über die Ätiologie und Diagnostik von Riech- und Schmeckstörungen zu geben. Da etwa 5 % der Allgemeinbevölkerung betroffen sind, ist es ein häufiges Krankheitsbild. Riechen und Schmecken erhielten v. a. zuletzt Aufmerksamkeit während des Aufkommens der SARS-CoV-2-Pandemie, wobei eine plötzlich aufgetretene Riech- und/oder Schmeckstörung zu den typischen Symptomen zählt. Daneben sind Riechstörungen in der Frühdiagnostik neurodegenerativer Erkrankungen von Bedeutung. Häufig zeigen Patienten mit Riechstörungen Zeichen einer Depression. Die Auswirkungen von Riech‑/Schmeckstörungen sind also umfangreich, die Therapiemöglichkeiten aktuell begrenzt. Nach einem Einblick in die Ätiologie werden Diagnostik und Therapiemöglichkeiten auf dem aktuellen Stand der Literatur erörtert. Auch zukunftsweisende Behandlungsvorstellungen, wie z. B. autologe Schleimhauttransplantationen oder olfaktorische Implantate, werden angesprochen.
- 12 January 2022
- Published by Springer Nature in HNO
- Vol. 70 (2) , 1-10
Riech- und Schmeckstörungen
Zusammenfassung Ziel der vorliegenden Übersicht ist es, einen Überblick über die Ätiologie und Diagnostik von Riech- und Schmeckstörungen zu geben. Da etwa 5 % der Allgemeinbevölkerung betroffen sind, ist es ein häufiges Krankheitsbild. Riechen und Schmecken erhielten v. a. zuletzt Aufmerksamkeit während des Aufkommens der SARS-CoV-2-Pandemie, wobei eine plötzlich aufgetretene Riech- und/oder Schmeckstörung zu den typischen Symptomen zählt. Daneben sind Riechstörungen in der Frühdiagnostik neurodegenerativer Erkrankungen von Bedeutung. Häufig zeigen Patienten mit Riechstörungen Zeichen einer Depression. Die Auswirkungen von Riech‑/Schmeckstörungen sind also umfangreich, die Therapiemöglichkeiten aktuell begrenzt. Nach einem Einblick in die Ätiologie werden Diagnostik und Therapiemöglichkeiten auf dem aktuellen Stand der Literatur erörtert. Auch zukunftsweisende Behandlungsvorstellungen, wie z. B. autologe Schleimhauttransplantationen oder olfaktorische Implantate, werden angesprochen.
- 12 October 2021
- Published by Georg Thieme Verlag KG in Laryngo-Rhino-Otologie
- Vol. 101 (03) , 241-244
Kanalikuläres Adenom im Epipharynx – ein Fallbericht
Received: 14 May 2021 Accepted after revision: 20 September 2021 Publication Date: 12 October 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 12 October 2021
- Published by Georg Thieme Verlag KG in Laryngo-Rhino-Otologie
- Vol. 101 (03) , 241-244
Kanalikuläres Adenom im Epipharynx – ein Fallbericht
Received: 14 May 2021 Accepted after revision: 20 September 2021 Publication Date: 12 October 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 1 May 2020
- Published by Georg Thieme Verlag KG
- Vol. 99 (S 02)
Endoskopische Nasennebenhöhlenchirurgie führt zu weniger Antibiotika- und oralem Steroidgebrauch bei chronischer Rhinosinusitis
Hintergrund:Antibiotika und oraler Steroidgebrauch für chronische Rhinosinusitis (CRS) spiegelt schlechte Krankheitskontrolle wieder.Wir untersuchten, ob endoskopische Nebenhöhlenchirurgie (ESS) den Gebrauch dieser systemischen Medikation beeinflusst. Material,Methoden:Prospektive longitudinale Studie mit 78 Patienten, welche eine umfassende ESS für medikamentös schwierig einstellbare CRS erfuhren.CRS Belastung anhand des SNOT-22 gemessen, CRS bezogener Antibiotika-und Steroidgebrauch in den letzten 3 Monaten zum Zeitpunkt der ESS und ein Jahr nach ESS erhoben. Ergebnisse:Nach ESS, Abnahme des SNOT-22 Wertes um durchschnittlich 22,8 Punkte, CRS bezogener Antibiotikagebrauch in den letzten 3 Monaten um durchschnittlich 1,1 und CRS bezogener oraler Steroidgebrauch in den letzten 3 Monaten um durchschnittlich 0,5 Mal.Bei Patienten, welche systemische Medikation präoperativ brauchten, sank die durchschnittliche Zahl der Antibiotikaverläufe um 1,7; durchschnittlicher Steroidgebrauch um 1.0. Veränderung im Antibiotikagebrauch assoziierte mit prä-operativem Antibiotikagebrauch (b=-1,1, 95 %KI: -0,9 bis -1,2, p<0,001), oralem Steroidgebrauch (b=0,3, 95 %KI: 0,1–0,5, p = 0,041) und Rauchen (b=2,0, 95 %KI: 0,9–3,1, p<0,001).Veränderung im oralen Steroidgebrauch assoziierte mit prä-operativem oralen Steroidgebrauch (b= -0,7, 95 %KI: -0,9 bis -0,6, p<0,001) und Antibiotikagebrauch (b= -0,1, 95 %KI: -0,2–0,0, p = 0,044).Prä-operativer SNOT-22 assoziierte nicht mit Veränderungen im Gebrauch systemischer Medikation. Diskussion:ESS reduziert den systemischen Antibiotika-und Steroidgebrauch für CRS, unabhängig von der CRS Symptomatologie.CRS bezogener Antibiotika-und Steroidgebrauch sind unabhängige Indikatoren für CRS Krankheitskontrolle, welche als ESS Ergebnis erhoben werden sollten. Poster-PDF A-1071.PDF Publication Date: 10 June 2020 (online) © . © Georg Thieme Verlag KG Stuttgart · New York
- 1 May 2020
- Published by Georg Thieme Verlag KG
- Vol. 99 (S 02)
Open AccessEndoskopische Nasennebenhöhlenchirurgie führt zu weniger Antibiotika- und oralem Steroidgebrauch bei chronischer Rhinosinusitis
Hintergrund:Antibiotika und oraler Steroidgebrauch für chronische Rhinosinusitis (CRS) spiegelt schlechte Krankheitskontrolle wieder.Wir untersuchten, ob endoskopische Nebenhöhlenchirurgie (ESS) den Gebrauch dieser systemischen Medikation beeinflusst. Material,Methoden:Prospektive longitudinale Studie mit 78 Patienten, welche eine umfassende ESS für medikamentös schwierig einstellbare CRS erfuhren.CRS Belastung anhand des SNOT-22 gemessen, CRS bezogener Antibiotika-und Steroidgebrauch in den letzten 3 Monaten zum Zeitpunkt der ESS und ein Jahr nach ESS erhoben. Ergebnisse:Nach ESS, Abnahme des SNOT-22 Wertes um durchschnittlich 22,8 Punkte, CRS bezogener Antibiotikagebrauch in den letzten 3 Monaten um durchschnittlich 1,1 und CRS bezogener oraler Steroidgebrauch in den letzten 3 Monaten um durchschnittlich 0,5 Mal.Bei Patienten, welche systemische Medikation präoperativ brauchten, sank die durchschnittliche Zahl der Antibiotikaverläufe um 1,7; durchschnittlicher Steroidgebrauch um 1.0. Veränderung im Antibiotikagebrauch assoziierte mit prä-operativem Antibiotikagebrauch (b=-1,1, 95 %KI: -0,9 bis -1,2, p<0,001), oralem Steroidgebrauch (b=0,3, 95 %KI: 0,1–0,5, p = 0,041) und Rauchen (b=2,0, 95 %KI: 0,9–3,1, p<0,001).Veränderung im oralen Steroidgebrauch assoziierte mit prä-operativem oralen Steroidgebrauch (b= -0,7, 95 %KI: -0,9 bis -0,6, p<0,001) und Antibiotikagebrauch (b= -0,1, 95 %KI: -0,2–0,0, p = 0,044).Prä-operativer SNOT-22 assoziierte nicht mit Veränderungen im Gebrauch systemischer Medikation. Diskussion:ESS reduziert den systemischen Antibiotika-und Steroidgebrauch für CRS, unabhängig von der CRS Symptomatologie.CRS bezogener Antibiotika-und Steroidgebrauch sind unabhängige Indikatoren für CRS Krankheitskontrolle, welche als ESS Ergebnis erhoben werden sollten. Poster-PDF A-1071.PDF Publication Date: 10 June 2020 (online) © . © Georg Thieme Verlag KG Stuttgart · New York